An interventional study of Peppermint Oil in Bladder and Bowel Dysfunction, sponsored by Children's Hospital of Orange County. Enrolling by invitation at 1 site in United States. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-04-08.
Sponsored by Children's Hospital of Orange County · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 93 studies in Intestinal Diseases with a site in United States — 16 open to participants now, 21 under way, 5 of them phase 3. Intestinal Diseases · United States.
Among the 93 studies in Intestinal Diseases with a site in United States, this one is the 55th largest by planned enrollment of the 74 interventional ones that give a count, is one of 5 that started in 2022, is one of 18 with no phase, reaches primary completion later than 3 of the 20 other live ones, and was the 76th registered.
260 studies on the registry are indexed under Intestinal Diseases; 53 are open to participants now.
Browse Intestinal Diseases studies →16 of the 93 studies in Intestinal Diseases with a site in United States are open now. Recruiting first, the newest first:
Ohio State University · Sites in United States
Ages 18–70
Paul Szabolcs · Sites in United States
Ages 5–40
Zealand Pharma · Sites in United States, Austria, Belgium and 11 more countries
Ages 18–90
Medtronic - MITG · Sites in United States
Ages 18+
Pfizer · Sites in United States, Argentina, Australia and 17 more countries
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 38 Intestinal Diseases studies recruiting now, 17 (45%) set no upper age limit and 17 (45%) stop at 75 or younger; 15 take children under 18; 6 take healthy volunteers.
This study: 8 Years to 17 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
93 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 25 · Phase 3 21 · Phase 4 8
First in 2002; this study’s year is marked. 5 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 67 across 180 interventional studies indexed under Intestinal Diseases.
Median enrollment 72 across the 74 interventional studies, 327 across the 18 observational. Of the 69 that completed or were terminated, 33 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
55 of 93 have an industry lead sponsor. The 10 most frequent:
Children's Hospital of Orange County is the lead sponsor of 19 studies on the registry; 11 are open to participants now.
Children's Hospital of Orange County has 1 study filed under Intestinal Diseases — fewer than ten, so there is no comparison to draw.
6 of the studies in Intestinal Diseases with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05776277Phase 3Cook MyoSiteIltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury | 2026-12 |
| NCT06137014Paul A BreslinFortified Oral Rehydration Therapy for Pediatric Diarrhea | 2026-12 |
| NCT05613153Children's Hospital of Orange CountyPeppermint Oil as a Treatment for Children With Bladder and Bowel Dysfunction | 2026-12-31 |
| NCT04937868University of California, Los AngelesDeveloping a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients | 2027-01-15 |
| NCT07351071Medtronic - MITGPost-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections | 2027-04-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 93 studies in Intestinal Diseases with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to study the effect of peppermint oil in in children with bladder and bowel dysfunction.
The main question it aims to answer is: Does peppermint oil improve symptoms of bladder and bowel dysfunction among children?
Participants will:
Researchers will compare baseline and follow-up questionnaire data for each participant to determine if there is improvement in symptoms of bladder and bowel dysfunction.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Peppermint oil will be provided free of charge to participants under the trademark Pepogest produced by the maker Nature's Way® (dosage 0.2 mL, 181 mg peppermint oil).
Dietary Supplement: Peppermint Oil
Participants weighing more than 40 kg will receive 2 peppermint oil capsules 3 times a day. Smaller children who weigh between 30 kg and 40 kg will receive 1 capsule of peppermint oil 3 times a day. All subjects will receive 8 weeks of treatment.
Symptom score
Vancouver Nonneurogenic Lower Urinary Tract Dysfunction/Dysfunctional Elimination Syndrome Questionnaire Score. This includes 13 items scored using a 5-point Likert scale for each item. A score of 0 denotes no complaints and a score of 4 indicates severe symptoms. Range of scores 0-54, with higher scores indicating a worse outcome.
Time frame: 8 weeks
Plan to share: No
Started Nov 2022 (actual). Primary completion is estimated for Dec 2026, 49 months after the start.
Of 55 non-industry interventional studies with no phase under Intestinal Diseases, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 43. This study's planned 49 months is above that.
Counting every sponsor, half of 64 studies reached it within 21 months; a quarter within 12 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Peppermint oil
Children's Hospital of Orange County